ARTICLE | Clinical News
Vargatef nintedanib regulatory update
January 5, 2015 8:00 AM UTC
The European Commission approved Vargatef nintedanib from Boehringer in combination with docetaxel to treat locally advanced, metastatic or locally recurrent non-small cell lung cancer (NSCLC) of aden...